Serums
Creams & Moisturizers
Eye Care
Cleansers & Toners
Masks & Treatments
Complexion & Glow
Body & Bath
Blue Copper 5 Firming Elasticity Repair — Clinical Results
Clinical Results
Blue Copper 5 Firming Elasticity Repair
Built on a matrikine peptide complex that is clinically dosed — carried at the level its research used, not a token trace. Here is the evidence.
What users saw in 8 weeks
Photography of an individual user following twice-daily use for 8 weeks. Individual results vary.
saw firmer, more elastic skin
saw a visible reduction in wrinkles
said their skin felt more supple
said their skin looked more youthful
Consumer perception study over 8 weeks of twice-daily use.
The ingredient evidence
Matrikine peptide complex
Clinically dosed — an exact match to the studied levelA matrikine peptide duo (palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7) that signals the skin to rebuild its collagen scaffolding. Firming Elasticity Repair carries it at the same concentration used in the clinical study below — the level at which these results were achieved.
| Clinical result vs placebo (2 months) | Figure |
|---|---|
| Surface area occupied by deep wrinkles (>200µm) | -44.9% |
| Main wrinkle density | -37.0% |
| Average wrinkle depth | -15.1% |
| Average wrinkle volume | -14.7% |
| Skin tone | +19.5% |
Method: Two panels of 23 volunteers aged 39–74; a cream containing the active applied to one half of the face and a placebo to the other, twice daily for 2 months; measured by confocal analysis of silicone skin imprints. Supplier clinical study of the ingredient; not conducted on the finished Osmotics product.
Laboratory evidence
In-vitro, same dossierIn fibroblast cultures, the same peptide complex significantly increased the synthesis of the skin’s core structural proteins.
| Protein synthesis | Increase |
|---|---|
| Collagen I | +258% |
| Hyaluronic acid | +179% |
| Fibronectin | +164% |
Method: In-vitro fibroblast culture study by the ingredient manufacturer. Laboratory results; not a measure of results on human skin.
Blue Copper (prezatide copper acetate)
The molecule Osmotics pioneered in 1998Copper peptides (GHK-Cu) are among the most-studied molecules in skin science, with peer-reviewed research going back to 1988 showing they stimulate collagen synthesis in fibroblasts and support the skin’s natural repair processes. Osmotics created the world’s first Blue Copper firming treatment in 1998.
References: Maquart et al., FEBS Letters, 1988 — stimulation of collagen synthesis in fibroblast cultures by GHK-Cu; and subsequent peer-reviewed literature on copper-peptide skin regeneration.